Nijman, Hans W.
University Medical Center Groningen · University of Groningen
6 papers on CoChatORCID 0000-0002-1821-3042
Most cited papers
- Verified
B lymphocytes secrete antigen-presenting vesicles.
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., & Geuze, H. J. (1996) · The Journal of experimental medicine
Extracellular vesicles in diseaseCellular transport and secretion
Cited by 3,546
- Verified
Refining prognosis and identifying targetable pathways for high-risk endometrial cancer: a TransPORTEC initiative.
Stelloo, E., Bosse, T., Nout, R. A., MacKay, H. J., Church, D. N., Nijman, H. W., Leary, A., Edmondson, R. J., Powell, M. E., Crosbie, E. J., et al. (2015) · Modern Pathology
Endometrial and Cervical Cancer TreatmentsBreast Cancer Treatment Studies
Cited by 486
- Verified
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: A retrospective, pooled biomarker study
Domingo, E., Freeman-Mills, L., Rayner, E., Glaire, M., Briggs, S., Vermeulen, L., Fessler, E., Medema, J. P., Boot, A., Morreau, H., et al. (2016) · The Lancet Gastroenterology & Hepatology
Genetic factors in colorectal cancerColorectal Cancer Treatments and Studies
Cited by 308
- Verified
Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
Speetjens, F. M., Kuppen, P. J. K., Welters, M. J. P., Essahsah, F., Voet van den Brink, A. M. E. G., Lantrua, M. G. K., Valentijn, A. R. P. M., Oostendorp, J., Fathers, L. M., Nijman, H. W., et al. (2009) · Clinical Cancer Research
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 185
- Verified
Strong vaccine responses during chemotherapy are associated with prolonged cancer survival
Melief, C. J. M., Welters, M. J. P., Vergote, I., Kroep, J. R., Kenter, G. G., Ottevanger, P. B., Tjalma, W. A. A., Denys, H., van Poelgeest, M. I. E., Nijman, H. W., et al. (2020) · Science Translational Medicine
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 134
- Verified
Long‐term clinical and immunological effects of p53‐SLP® vaccine in patients with ovarian cancer
Leffers, N., Vermeij, R., Hoogeboom, B., Schulze, U. R., Wolf, R., Hamming, I. E., van der Zee, A. G., Melief, K. J., van der Burg, S. H., Daemen, T., et al. (2012) · International Journal of Cancer
Immunotherapy and Immune ResponsesOvarian cancer diagnosis and treatment
Cited by 60
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free